Vera Therapeutics, Inc. (VERA)
NASDAQ: VERA · Real-Time Price · USD
30.34
+0.61 (2.05%)
Oct 9, 2026, 10:14 AM EDT - Market open
Vera Therapeutics Market Cap
Vera Therapeutics has a market cap or net worth of $2.19 billion as of October 9, 2026. It is the 6,468th most valuable company in the world and the 1,721st biggest in the United States. Its market cap has increased by 12.32% in one year.
Market Cap
2.19B
Enterprise Value
1.76B
1-Year Change
12.32%
Global Rank
Country Rank
#1,721 United States
Category
ChartMarket Cap Chart
Since the IPO on May 14, 2021, Vera Therapeutics's market cap has increased from $225.27M to $2.19B, an increase of 870.56%. That is a compound annual growth rate of 52.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 2.19B | -39.18% |
| Dec 31, 2025 | 3.59B | 34.24% |
| Dec 31, 2024 | 2.68B | 291.87% |
| Dec 29, 2023 | 683.38M | 27.69% |
| Dec 30, 2022 | 535.18M | -5.87% |
| Dec 31, 2021 | 568.54M | 152.38% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 2.36B |
| Disc Medicine | 2.35B |
| Harmony Biosciences Holdings | 2.29B |
| Recursion Pharmaceuticals | 2.29B |
| SELLAS Life Sciences Group | 2.28B |
| ADMA Biologics | 2.27B |
| Pharvaris | 2.22B |
| Immunome | 2.17B |